Idera Pharma (IDRA) Tops Q4 EPS by 1c

Idera Pharma (NASDAQ: IDRA) reported Q4 EPS of ($0.10), $0.01 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Idera Pharma (IDRA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c